Newsroom

SAN FRANCISCO--(BUSINESS WIRE)--Zeitro, a mortgage technology company, today announced the availability of Scenario AI, an agentic AI designed to help mortgage professionals evaluate borrower eligibility and compare underwriting guidelines. Scenario AI brings AI-powered loan programs and eligibility evaluation into the professional mortgage origination workflow, querying thousands of programs simultaneously, enabling mortgage professionals to assess scenarios and allocate time and resources mor...

DUBLIN--(BUSINESS WIRE)--The "B2C Ecommerce Global Market Size & Forecast by Value and Volume Across 80+ KPIs - Databook Q4 2025 Update" has been added to ResearchAndMarkets.com's offering. The global ecommerce market is on a promising trajectory, with projections indicating a growth rate of 7.3% annually, reaching a staggering US$7.25 trillion by 2025. Between 2020 and 2024, the market exhibited a robust CAGR of 9.5%, and this trend is anticipated to continue with a forecasted CAGR of 6.2%...

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced the formation and planned initial public offering (“IPO”) of Janus Living, Inc. (collectively with its subsidiaries, “Janus Living”), a real estate investment trust (“REIT”) dedicated to senior housing. Healthpeak will contribute its 34-community, 10,422-unit senior housing portfolio to Janus Living and wi...

NEW YORK--(BUSINESS WIRE)--CCMP Growth Advisors, LP (“CCMP Growth”), a private equity firm that partners with high growth, lower middle market industrial and consumer companies to build enduring growth, is pleased to announce that it has appointed Managing Director Patrick McGrath to the firm’s Investment Committee and made the following additional firmwide promotions, effective January 1, 2026: Chris Stevenson to Senior Principal Casey Klingler to Principal Connor Moran to Principal Jamie Flan...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stylus Medicine, Inc. (“Stylus”), a biotechnology company dedicated to developing transformative in vivo genetic medicines, today announced that Emile Nuwaysir, Ph.D., chairman and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 5:00 p.m. PT. About Stylus Medicine Stylus Medicine is developing transformative in vivo genetic medicines to unlock cures, starting with in vivo CAR-T therapie...

NEW YORK & LONDON--(BUSINESS WIRE)--KKR, a leading global investment firm, today announced that it is making an additional $1.5 billion equity commitment to Global Technical Realty (“GTR”), a multi-billion dollar European built-to-suit data center platform. In connection with this investment, Oak Hill Capital (“Oak Hill”), a thematic, middle-market private equity firm, will join as an investor in the company, committing approximately $400 million. Founded by leading data center entrepreneur Fra...

SANTA CLARA, Calif.--(BUSINESS WIRE)--PlusAI, a leader in AI software for autonomous trucks, today announced that members of its senior management team are scheduled to participate in the following investor conference in January. 28th Annual Needham Growth Conference January 15, 2026 Virtual Management will be conducting one-on-one meetings with investors in attendance at the conference. Interested investors should contact their Needham sales representative. About PlusAI PlusAI is an artificial...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today provided corporate updates and highlighted upcoming milestones for 2026. “Heading into 2026, we are proud of the strong execution across our pipeline. Since reporting data in October from our prula-cel Phase 1 program in autoimmune diseases, enrollment has more than doubled with...

NEW YORK--(BUSINESS WIRE)--Volastra Therapeutics, a clinical-stage biotechnology company pioneering first-in-class therapies targeting chromosomal instability (CIN) in cancer, today announced a significant expansion of its clinical development program driven by encouraging clinical data from its lead KIF18A inhibitor (KIF18Ai), a key investigational CIN-targeted cancer therapy. The company also highlighted continued advancement across its strategic pipeline and the appointment of Timothy Bowler...

SANTA CLARA, Calif.--(BUSINESS WIRE)--PlusAI, a leader in AI software for autonomous trucks, today announced the appointment of two new Board members, David C. Peterschmidt and Harry J. Harczak, Jr., seasoned leaders with decades of public company experience in technology and finance. The appointment will become effective upon PlusAI’s planned public listing via a business combination with Churchill Capital Corp IX (NASDAQ: CCIX). David C. Peterschmidt previously served as Chairman and CEO of I...